Home / Guggenheim and Rydex / RYDEX VARIABLE TRUST / VT BIOTECHNOLOGY FUND
VT BIOTECHNOLOGY FUND
A series of RYDEX VARIABLE TRUST
- Vote records
- 627year to 30 June 2026
- Against management
- 18.2%114 of 627 marked votes
- Say-on-pay support
- 78.5%for, of for + against + abstain
- Shareholder-proposal support
- 42.9%for, of for + against + abstain
VT BIOTECHNOLOGY FUND is a series of RYDEX VARIABLE TRUST. For the year to 30 June 2026 its registrant reported 627 vote records for the series; 18.2% of the votes marked for or against management went against management. It voted for 78.5% of say-on-pay items and for 42.9% of proposals from security holders.
Compared with its registrant and family
| year to 30 June 2026 | This series | Its registrant | Guggenheim and Rydex | Median fund registrant |
|---|---|---|---|---|
| Against-management share | 18.2% | 10.1% | 10.8% | 6.2% |
| Say-on-pay support rate | 78.5% | 87.8% | 87.3% | 91.6% |
| Shareholder-proposal support rate | 42.9% | 35.3% | 35.9% | 27.5% |
Votes by category
foragainstabstain, withhold or otheramber tick: the portion cast against management
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 368 | 293 | 13 | 20.4% | |
| SECTION 14A SAY-ON-PAY VOTES | 73 | 53 | 14 | 19.2% | |
| AUDIT-RELATED | 72 | 72 | 0 | 0.0% | |
| EXTRAORDINARY TRANSACTIONS | 5 | 5 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 25 | 23 | 2 | 8.0% | |
| COMPENSATION | 46 | 30 | 16 | 34.8% | |
| CORPORATE GOVERNANCE | 42 | 35 | 7 | 19.0% | |
| ENVIRONMENT OR CLIMATE | 2 | 1 | 1 | 0.0% | |
| HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE | 1 | 1 | 0 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 2 | 1 | 1 | 0.0% | |
| OTHER SOCIAL ISSUES | 4 | 2 | 2 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|---|
| year to 30 June 2024 | 573 | 13.8% | 91.5% | 77.8% |
| year to 30 June 2025 | 680 | 14.7% | 78.6% | 33.3% |
| year to 30 June 2026 | 627 | 18.2% | 78.5% | 42.9% |
Questions
How often did VT BIOTECHNOLOGY FUND vote against management?
18.2% of the votes its registrant marked for or against management in the year to 30 June 2026 (114 of 627).
How did VT BIOTECHNOLOGY FUND vote on executive pay?
It voted for 51 of 65 say-on-pay items cast for, against or abstain (78.5%).
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other shareholders voted or what the outcome was.
Where does the data come from?
From the Form N-PX filed by RYDEX VARIABLE TRUST, which lists the series that cast each vote. The SEC does not verify the contents. Data runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX filed by RYDEX VARIABLE TRUST (filer no. 1064046); votes attributed to series S000003711 by the filer. Not verified by the SEC. Filings read through 23 Sep 2026.